Benefits
Weight Management with Enhanced Bioavailability
GarCitrin combines HCA (active compound for fat metabolism and appetite) with BioPerine for enhanced bioavailability — addresses absorption limitations of standalone Garcinia products.
Appetite Control and Satiety
HCA component provides documented satiety effects via serotonin pathway; modest food intake reduction in clinical trials.
Carbohydrate-to-Fat Conversion Inhibition
HCA inhibits ATP-citrate lyase enzyme reducing carbohydrate conversion to stored fat; mechanism distinct from appetite suppression.
BioPerine Bioavailability Enhancement
Piperine component enhances absorption of HCA and supports overall metabolic effects.
Patented Sabinsa Combination
Sabinsa's patented GarCitrin formulation provides specific HCA + piperine ratio with research backing.
Mechanism of action
ATP-Citrate Lyase Inhibition (HCA)
Same as Super CitriMax — HCA inhibits ATP-citrate lyase reducing fatty acid synthesis from carbohydrates.
Serotonin / Satiety Pathway
HCA modulates serotonin pathway — relevant to satiety and food cravings.
BioPerine Bioavailability Enhancement
Piperine inhibits CYP3A4 and P-glycoprotein — enhances absorption of co-administered HCA.
Combined Fat Metabolism Support
Multi-pathway approach to weight management vs single-mechanism ingredients.
Clinical trials
Sabinsa clinical studies of GarCitrin formulation for weight management.
Adults with weight management concerns.
Improvements in body composition markers and satiety.
General Garcinia/HCA evidence base across multiple branded forms.
Various populations.
Modest weight management effects; effect size variable; bioavailable forms more reliable.
About this ingredient
GARCITRIN® is a PROPRIETARY GARCINIA CAMBOGIA + BIOPERINE® formulation developed by SABINSA CORPORATION — combining HCA (hydroxycitric acid) with patented piperine. HCA SOURCE: GARCINIA CAMBOGIA fruit rind; calcium-potassium HCA salt for stability and bioavailability. BIOPERINE COMPONENT: same Sabinsa patented black pepper extract (≥95% piperine) used as bioavailability enhancer.
KEY DISTINCTIONS: (1) PATENTED Sabinsa combination formulation; (2) HCA + BioPerine synergy; (3) Self-affirmed GRAS; (4) Sabinsa research and quality.
EVIDENCE-BASED USES: (1) Weight management adjunct; (2) Appetite control and satiety; (3) Carbohydrate-to-fat conversion inhibition; (4) Multi-pathway fat metabolism support.
CRITICAL CAUTIONS: (1) HEPATOTOXICITY — same Garcinia/HCA hepatotoxicity considerations as Super CitriMax; AVOID with liver disease; monitor; (2) BIOPERINE DRUG INTERACTIONS — CYP3A4 inhibition affects many medications; CONSULT prescriber; (3) PREGNANCY — limited safety data; AVOID; (4) DIABETES MEDICATIONS — modest hypoglycemic effects; (5) DOSE — per Sabinsa specification; (6) GARCITRIN vs SUPER CITRIMAX (Lonza) — both branded HCA forms; GarCitrin includes BioPerine for enhanced bioavailability; Super CitriMax is calcium-HCA standalone; both have evidence; (7) WEIGHT MANAGEMENT FRAMEWORK — caloric deficit, exercise, behavior change, sleep foundational; supplements adjunct with modest effects; (8) HCA EVIDENCE OVERVIEW — modest effects across studies; bioavailability-enhanced forms more reliable; (9) BIOPERINE COMPONENT — same considerations as standalone BioPerine including drug interactions; (10) BRAND VERIFICATION — GarCitrin® is Sabinsa trademark; specific patented combination; (11) For COMPREHENSIVE WEIGHT MANAGEMENT — supplementation modest tool; lifestyle foundational.